X
Did you know that you could take #VaccinAction in 2022 and talk to your healthcare professional today?
Italy’s experience with pneumococcal vaccination points the way forward in fighting respiratory illnesses. Read the article written by Active Citizenship Network Director and just published on VaccineToday.
In the framework of the media partnership with Epidemiology and Public Health Research (EPHR), a journal focused on research and reports discussing about public health, epidemiology and progress that have been made to enhance societies' healthcare internationally, Active Citizenship Network has published, last December 2021, a manuscript entitled “Influenza vaccination at the time of Covid-19: From the Italian case history to the “EU Flu Day”, discussing about how the national (Italian) and European contexts managed the administration of flu vaccination during the Covid-19 pandemic. To do this, the article puts forward the results emerged from the civic survey on the supply of flu vaccine doses conducted by Cittadinanzattiva in September 2020 across Italy and introduces the second EU survey entitled "Addressing the challenges of concomitant deployment of COVID-19 and influenza vaccination" launched by ACN on the occasion of the EU Flu Day 2021.
Last 22 April 2022, Active Citizenship Network has published an article entitled “Addressing the Challenges of COVID-19 Pandemic on the Routine Vaccinations across Europe: Focus on Flu Vaccination” on the International Journal of Virology & Infectious Diseases, an international, peer reviewed, open access, scholarly journal that brings about latest research in all related aspects of virology and infectious diseases. The published manuscript discusses about the challenges of dealing with the concomitant deployment of COVID-19 and influenza vaccination, exploring the results emerged from the II EU online survey, realized in October-November 2021 by Active Citizenship Network in the framework of its #VaccinAction2021 EU project entitled “Protecting the value of vaccination during - and after - the COVID-19 pandemic across Europe: impact, experiences and perspectives from citizens’ and patients’ advocacy groups & relevant stakeholders”.
Last 2 September 2022, Active Citizenship Network published a new manuscript dealing with the significance of adult vaccination entitled “Addressing the Burden of the Vaccine-Preventable Respiratory Diseases: From the Pneumococcal Vaccination Case Study in Italy to the EU Council Conclusion on (adult) Vaccination”on the SL Vaccines and Vaccination Journal, an international peer-reviewed journal publishing novel fundamental and applied research related to all aspects of vaccines and vaccination. The article examines the growing burden that the trio of vaccine-preventable respiratory diseases (VPRDs), namely pneumococcal pneumonia, Covid-19 and flu, have been placing on healthcare systems among European countries. This is evidenced greatly by the data emerged from the EU survey “Pneumococcal Vaccination in adults: proposals for a fair and informed access”, carried out by Cittadinanzattiva in Italy in the 2021-2022 winter season and presented also at the EU level during the event realized by Active Citizenship Network last 7 July 2022 titled “Towards the next Council conclusions: which role of adult vaccination?”.
The pandemic has shown both the importance of vaccination and the vulnerabilities of the vaccine ecosystem that lead to a decreased availability of high-quality, safe, and effective products for everyone. Vaccines Europe’s members have analyzed the leading causes of vaccine shortages in Europe and discovered that the diversity of presentations, packs and labels in the EU is one of them.
Active Citizenship Network (ACN) has held on July 7th this EU Webinar as a follow up to the Annual Meeting of the Coalition for Vaccination, and at the beginning of the Czech Semester, the initiative has allowed discussion of the EU Institutions' commitment to Adult Vaccination: what weight will the topic of vaccinations have in the Council Conclusions scheduled for December? How the different health stakeholders (civil society, patients, health professionals, experts, and institutions) can work together on this, and what role adult vaccinations will play in the Conclusions?
The event, hosted by the MEPs Interest Group "European Patients' Rights & CrossBorder Healthcare, was realized in the framework of the VaccinAction2022 EU project, focused on supporting the need for strengthening adult vaccination in Europe and, starting from the citizens’ and healthcare stakeholders’ perspective, understanding the impact of the COVID-19 pandemic and vaccination campaign on the national immunisation plans, protecting the value of the adult immunisation and its gains. Hence the communication campaign’s first subject that will be launched soon.
ACN supports the SymptomSurvey, a collaboration between the Vienna Vaccine Safety Initiative and civil/advocacy organisations (Families Fighting Flu, Make Mothers Matter, the European Parents’ Association, Think Young) and the European Academy of Pediatrics. The survey’s goal is to understand better a person’s/patient’s subjective experience of flu-like symptoms and COVID and how this may relate to a person’s willingness to get vaccinated and/or seek treatment to prevent or mitigate symptoms. Completing the questionnaire will take you about 30 minutes, and the obtained insights will be used for informing the healthcare system and improving patients' positions.
The Adult Vaccination Advocacy Toolkit (AVAT), responding to an urgent call from stakeholders and advocacy groups, has come to life also thanks to ACN’s contribution. The toolkit is designed to help build the capacity and capability to influence and shape adult vaccination policy at local, national, and global levels through an evidence-to-action model of engagement across sectors and disciplines.
The positive impacts of vaccination and vaccination policies in combating the global health threat of antimicrobial resistance (AMR) were discussed in the framework of the training seminar dedicated to antimicrobial resistance entitled “Resistenza antimicrobica: una minaccia globale. Cosa sapere per meglio affrontarla a livello locale” and realized by Active Citizenship Network on 4 July 2022.
Cittadinanzattiva APS
p.iva: 02142701008
via Imera, 2
00183 Roma
Tel: (+39) 06.36.71.81
Fax: (+39) 06.36.71.83.33
Rue Philippe Le Bon, 46
1000 Brussels - Belgium
